首页 > 最新文献

Chinese Journal of Plastic and Reconstructive Surgery最新文献

英文 中文
Hyaluronic acid injection in the auricular base for the aesthetic correction of lying ears: A retrospective study 耳根透明质酸注射用于卧耳美容的回顾性研究
Pub Date : 2023-03-01 DOI: 10.1016/j.cjprs.2023.02.004
Zhezhen Xiong , Zhengzheng Jiang , Yaping Bai , Minxue Liang , Weitai Jiang , Kai Liu

Background

Ears play an important role in facial profiles. Lying ears are not perceived favorably in Asian cultures; therefore, surgical procedures are implemented to adjust this defect. However, surgery has complications and requires recovery time. We introduced a hyaluronic acid (HA) injection technique to aesthetically improve ear prominence.

Methods

This retrospective study examined 25 Chinese patients aged 20–47 years with congenital lying ears who received HA injections in the auricular base at Shanghai Ninth People’s Hospital and Hangzhou Yijie Medical Cosmetology Clinic between November 2019 and December 2022. The average injection volume was 6.32 ​± ​1.22 mL in the auricular base unilaterally, and the follow-up time ranged from 6 to 24 months. Morphological measurement data were recorded. Two-dimensional (2D) and three-dimensional (3D) images were obtained to evaluate the effects.

Results

All patients showed improvements in ear prominence. The cranioauricular angle (CAA) increased from 22.24° ​± ​4.53° to 65.90° ​± ​5.38° immediately post-injection and was maintained at 49.18° ​± ​4.74° 6 months later. The ear projection (EP) increased from 14.75 ​± ​2.72 mm to 26.26 ​± ​2.94 mm immediately post-injection and was 22.51 ​± ​2.68 mm after 6 months. No serious complications were noted.

Conclusion

HA injection in the auricular base effectively corrected the lying ears and aesthetically optimized the facial profile. It also had a face-lift effect that made the face look younger and more compact. The injection procedure was minimally invasive and required no recovery period. The effect was maintained for a long time and was satisfactory.

背景在面部轮廓中扮演着重要的角色。说谎的耳朵在亚洲文化中是不受欢迎的;因此,采用外科手术来调整这一缺陷。然而,手术有并发症,需要恢复时间。我们介绍了一种透明质酸(HA)注射技术,以美观地改善耳突。方法回顾性分析2019年11月至2022年12月在上海市第九人民医院和杭州益杰医学美容诊所耳穴基底行HA注射的25例20-47岁先天性卧耳患者。平均单侧耳底注射量为6.32±1.22 mL,随访6 ~ 24个月。记录形态学测量数据。获得二维(2D)和三维(3D)图像来评估效果。结果所有患者耳部突出均有改善。颅耳角(CAA)由注射后即刻的22.24°±4.53°增加到65.90°±5.38°,6个月后维持在49.18°±4.74°。耳突(EP)由注射后立即的14.75±2.72 mm增加到26.26±2.94 mm, 6个月后增加到22.51±2.68 mm。无严重并发症。结论耳底注射透明质酸能有效矫正躺耳,改善面部轮廓。它也有拉脸的效果,使脸看起来更年轻,更紧致。注射过程是微创的,不需要恢复期。效果保持较长时间,令人满意。
{"title":"Hyaluronic acid injection in the auricular base for the aesthetic correction of lying ears: A retrospective study","authors":"Zhezhen Xiong ,&nbsp;Zhengzheng Jiang ,&nbsp;Yaping Bai ,&nbsp;Minxue Liang ,&nbsp;Weitai Jiang ,&nbsp;Kai Liu","doi":"10.1016/j.cjprs.2023.02.004","DOIUrl":"10.1016/j.cjprs.2023.02.004","url":null,"abstract":"<div><h3>Background</h3><p>Ears play an important role in facial profiles. Lying ears are not perceived favorably in Asian cultures; therefore, surgical procedures are implemented to adjust this defect. However, surgery has complications and requires recovery time. We introduced a hyaluronic acid (HA) injection technique to aesthetically improve ear prominence.</p></div><div><h3>Methods</h3><p>This retrospective study examined 25 Chinese patients aged 20–47 years with congenital lying ears who received HA injections in the auricular base at Shanghai Ninth People’s Hospital and Hangzhou Yijie Medical Cosmetology Clinic between November 2019 and December 2022. The average injection volume was 6.32 ​± ​1.22 mL in the auricular base unilaterally, and the follow-up time ranged from 6 to 24 months. Morphological measurement data were recorded. Two-dimensional (2D) and three-dimensional (3D) images were obtained to evaluate the effects.</p></div><div><h3>Results</h3><p>All patients showed improvements in ear prominence. The cranioauricular angle (CAA) increased from 22.24° ​± ​4.53° to 65.90° ​± ​5.38° immediately post-injection and was maintained at 49.18° ​± ​4.74° 6 months later. The ear projection (EP) increased from 14.75 ​± ​2.72 mm to 26.26 ​± ​2.94 mm immediately post-injection and was 22.51 ​± ​2.68 mm after 6 months. No serious complications were noted.</p></div><div><h3>Conclusion</h3><p>HA injection in the auricular base effectively corrected the lying ears and aesthetically optimized the facial profile. It also had a face-lift effect that made the face look younger and more compact. The injection procedure was minimally invasive and required no recovery period. The effect was maintained for a long time and was satisfactory.</p></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 1","pages":"Pages 8-12"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44464814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Handy locoregional flaps for nasal reconstruction 方便的局部皮瓣鼻部重建
Pub Date : 2023-03-01 DOI: 10.1016/j.cjprs.2023.03.001
Ahmed Hassan El-Sabbagh

Background

Skin lesions on the nose are common. Multiple surgical techniques have been used for nasal reconstruction. These options may be autogenous or alloplastic and can be performed in single or multiple stages. The choice of coverage depends on the nature of the lesion, location on the nose, and available donor sites. This study aimed to evaluate the surgical outcomes of using locoregional flaps for nasal reconstruction.

Methods

A total of 27 patients underwent surgery. There were 9 men and 18 women, aged 7 months to 93 years. Four patients presented with involuting hemangioma, five patients with ischemic necrosis of the columella, and five patients with congenital nevus; the remaining 13 patients were previously diagnosed with basal cell carcinoma. Six techniques have been described for nasal reconstruction at our institution from 2016 to 2020. Most patients had basal cell carcinoma (n=13). Locoregional flaps and primary sutures were used for nasal reconstruction.

Results

The complications were minimal. One patient had a superficial infection and one experienced postoperative bleeding. No recurrence was observed, and none of the patients asked for a second opinion.

Conclusion

Radical excision of tumors combined with analysis of nasal defects and nearby donor sites is essential for nasal reconstruction. The use of locoregional flaps leads to consistent and good aesthetic outcomes.

鼻子上的皮肤损伤是常见的。多种手术技术已被用于鼻重建。这些选择可以是自体的或同种异体的,可以在单个或多个阶段进行。覆盖范围的选择取决于病变的性质、鼻子上的位置和可用的供体部位。本研究旨在评估局部皮瓣鼻部重建的手术效果。方法27例患者行手术治疗。男9例,女18例,年龄7个月至93岁。4例为渐开式血管瘤,5例为小柱缺血性坏死,5例为先天性痣;其余13例患者先前被诊断为基底细胞癌。从2016年到2020年,我们已经描述了六种鼻部重建技术。大多数患者为基底细胞癌(n=13)。采用局部皮瓣和一期缝合进行鼻部重建。结果手术并发症极少。1例患者有浅表感染,1例患者术后出血。没有观察到复发,也没有患者要求第二意见。结论肿瘤根治性切除结合鼻部缺损及邻近供区分析是鼻部再造术的基础。局部皮瓣的使用带来了一致和良好的美学效果。
{"title":"Handy locoregional flaps for nasal reconstruction","authors":"Ahmed Hassan El-Sabbagh","doi":"10.1016/j.cjprs.2023.03.001","DOIUrl":"10.1016/j.cjprs.2023.03.001","url":null,"abstract":"<div><h3>Background</h3><p>Skin lesions on the nose are common. Multiple surgical techniques have been used for nasal reconstruction. These options may be autogenous or alloplastic and can be performed in single or multiple stages. The choice of coverage depends on the nature of the lesion, location on the nose, and available donor sites. This study aimed to evaluate the surgical outcomes of using locoregional flaps for nasal reconstruction.</p></div><div><h3>Methods</h3><p>A total of 27 patients underwent surgery. There were 9 men and 18 women, aged 7 months to 93 years. Four patients presented with involuting hemangioma, five patients with ischemic necrosis of the columella, and five patients with congenital nevus; the remaining 13 patients were previously diagnosed with basal cell carcinoma. Six techniques have been described for nasal reconstruction at our institution from 2016 to 2020. Most patients had basal cell carcinoma (<em>n</em>=13). Locoregional flaps and primary sutures were used for nasal reconstruction.</p></div><div><h3>Results</h3><p>The complications were minimal. One patient had a superficial infection and one experienced postoperative bleeding. No recurrence was observed, and none of the patients asked for a second opinion.</p></div><div><h3>Conclusion</h3><p>Radical excision of tumors combined with analysis of nasal defects and nearby donor sites is essential for nasal reconstruction. The use of locoregional flaps leads to consistent and good aesthetic outcomes.</p></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"5 1","pages":"Pages 13-19"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45573445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DeepPurpose-based drug discovery in chondrosarcoma 基于深层目的的软骨肉瘤药物发现
Pub Date : 2022-12-01 DOI: 10.1016/j.cjprs.2022.10.004
Jianrui Li , Mingyue Shi , Zhiwei Chen , Yuyan Pan

Background

Chondrosarcoma (CS) is the second most common primary bone tumor, accounting for approximately 30% of all malignant bone tumors. Unfortunately, the efficacy of currently available drug therapies is limited. Therefore, this study aimed to explore drug therapies for CS using novel computational methods.

Methods

In this study, text mining, GeneCodis STRING, and Cytoscape were used to identify genes closely related to CS, and the Drug Gene Interaction Database (DGIdb) was used to select drugs targeting the genes. Drug-target interaction prediction was performed using DeepPurpose, to finally obtain candidate drugs with the highest predicted binding affinities.

Results

Text-mining searches identified 168 genes related to CS. Gene enrichment and protein-protein interaction analysis generated 14 genes representing 10 pathways using GeneCodis, STRING, and Cytoscape. Seventy drugs targeting genes closely related to CS were analyzed using DGIdb. DeepPurpose recommended 25 drugs, including integrin beta 3 inhibitors, hypoxia-inducible factor 1 alpha inhibitors, E1A binding protein P300 inhibitors, vascular endothelial growth factor A inhibitors, AKT1 inhibitors, tumor necrosis factor inhibitors, transforming growth factor beta 1 inhibitors, interleukin 6 inhibitors, mitogen-activated protein kinase 1 inhibitors, and protein tyrosine kinase inhibitors.

Conclusion

Drug discovery using in silico text mining and DeepPurpose may be an effective method to explore drugs targeting genes related to CS.

软骨肉瘤(CS)是第二常见的原发性骨肿瘤,约占所有恶性骨肿瘤的30%。不幸的是,目前可用的药物治疗效果有限。因此,本研究旨在利用新的计算方法探索CS的药物治疗方法。方法本研究采用文本挖掘、GeneCodis STRING和Cytoscape等方法鉴定与CS密切相关的基因,并利用药物基因相互作用数据库(Drug Gene Interaction Database, DGIdb)筛选靶向基因的药物。利用deepurpose进行药物-靶标相互作用预测,最终获得预测结合亲和力最高的候选药物。结果文本挖掘检索鉴定出168个与CS相关的基因。基因富集和蛋白相互作用分析使用GeneCodis, STRING和Cytoscape生成了代表10条途径的14个基因。使用DGIdb分析了70个与CS密切相关的药物靶向基因。deepurpose推荐了25种药物,包括整合素β 3抑制剂、缺氧诱导因子1 α抑制剂、E1A结合蛋白P300抑制剂、血管内皮生长因子A抑制剂、AKT1抑制剂、肿瘤坏死因子抑制剂、转化生长因子β 1抑制剂、白细胞介素6抑制剂、丝裂原活化蛋白激酶1抑制剂、蛋白酪氨酸激酶抑制剂。结论基于计算机文本挖掘和DeepPurpose的药物发现可能是探索CS相关基因靶向药物的有效方法。
{"title":"DeepPurpose-based drug discovery in chondrosarcoma","authors":"Jianrui Li ,&nbsp;Mingyue Shi ,&nbsp;Zhiwei Chen ,&nbsp;Yuyan Pan","doi":"10.1016/j.cjprs.2022.10.004","DOIUrl":"10.1016/j.cjprs.2022.10.004","url":null,"abstract":"<div><h3>Background</h3><p>Chondrosarcoma (CS) is the second most common primary bone tumor, accounting for approximately 30% of all malignant bone tumors. Unfortunately, the efficacy of currently available drug therapies is limited. Therefore, this study aimed to explore drug therapies for CS using novel computational methods.</p></div><div><h3>Methods</h3><p>In this study, text mining, GeneCodis STRING, and Cytoscape were used to identify genes closely related to CS, and the Drug Gene Interaction Database (DGIdb) was used to select drugs targeting the genes. Drug-target interaction prediction was performed using DeepPurpose, to finally obtain candidate drugs with the highest predicted binding affinities.</p></div><div><h3>Results</h3><p>Text-mining searches identified 168 genes related to CS. Gene enrichment and protein-protein interaction analysis generated 14 genes representing 10 pathways using GeneCodis, STRING, and Cytoscape. Seventy drugs targeting genes closely related to CS were analyzed using DGIdb. DeepPurpose recommended 25 drugs, including integrin beta 3 inhibitors, hypoxia-inducible factor 1 alpha inhibitors, E1A binding protein P300 inhibitors, vascular endothelial growth factor A inhibitors, AKT1 inhibitors, tumor necrosis factor inhibitors, transforming growth factor beta 1 inhibitors, interleukin 6 inhibitors, mitogen-activated protein kinase 1 inhibitors, and protein tyrosine kinase inhibitors.</p></div><div><h3>Conclusion</h3><p>Drug discovery using <em>in silico</em> text mining and DeepPurpose may be an effective method to explore drugs targeting genes related to CS.</p></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"4 4","pages":"Pages 158-165"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096691122000760/pdfft?md5=46cd87d0aeec5cc0806f58635f76e9d5&pid=1-s2.0-S2096691122000760-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46571030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rhinoplasty in China: A review of the most important events in its history of development 中国鼻整形术:回顾其发展史上最重要的事件
Pub Date : 2022-12-01 DOI: 10.1016/j.cjprs.2022.08.005
Shengli Li, Qingfeng Li

A review of the literature in commonly used retrieval systems generally yields minimal or no pertinent information on the early works of Chinese doctors. Herein, the early works in rhinoplasty by pioneers Dr. Maolian Hu (胡懋廉) and Dr. PC Nyi (倪葆春) were retrieved from the database of Chinese Medical Journal published before 1949 that overseas doctors could not gain access to online possibly due to the language barrier in collecting and processing those old professional data by main retrieval systyems. They published original articles on costal cartilage applications for correction of saddle noses in as early as 1939 and 1949, respectively, which represent the earliest attempts of treating nasal deformities with costal cartilages in China as well as in Asia. The private cosmetic surgical practices in rhinoplasty from the 1930s to the 1940s were recovered and briefly reviewed, and some of the most important clinical cases were presented. Other important events related to rhinoplasty, such as the establishment of the first national society of rhinoplasty in Chengdu, China in 2011 and the successful performance of the first national congress on rhinoplasty in Shanghai, China in 2012, were included.

在常用的检索系统中查阅文献,通常很少或根本没有关于中国医生早期著作的相关信息。本文从1949年以前出版的《中华医学杂志》数据库中检索到鼻部整形先驱胡茂莲博士(http://www.懋)和倪永平博士(http://www.葆)的早期著作,由于主要检索系统在收集和处理这些旧的专业数据时存在语言障碍,海外医生无法在线访问这些数据库。他们分别早在1939年和1949年就发表了关于肋软骨应用于鞍鼻矫正的原创文章,这是中国乃至亚洲最早尝试用肋软骨治疗鼻畸形的尝试。本文对20世纪30年代至40年代的私人整形外科隆鼻手术进行了简要回顾,并介绍了一些最重要的临床病例。其他与鼻整形相关的重要事件,如2011年在中国成都成立了第一届全国鼻整形学会,2012年在中国上海成功举办了第一届全国鼻整形大会。
{"title":"Rhinoplasty in China: A review of the most important events in its history of development","authors":"Shengli Li,&nbsp;Qingfeng Li","doi":"10.1016/j.cjprs.2022.08.005","DOIUrl":"10.1016/j.cjprs.2022.08.005","url":null,"abstract":"<div><p>A review of the literature in commonly used retrieval systems generally yields minimal or no pertinent information on the early works of Chinese doctors. Herein, the early works in rhinoplasty by pioneers Dr. Maolian Hu (胡懋廉) and Dr. PC Nyi (倪葆春) were retrieved from the database of <em>Chinese Medical Journal</em> published before 1949 that overseas doctors could not gain access to online possibly due to the language barrier in collecting and processing those old professional data by main retrieval systyems. They published original articles on costal cartilage applications for correction of saddle noses in as early as 1939 and 1949, respectively, which represent the earliest attempts of treating nasal deformities with costal cartilages in China as well as in Asia. The private cosmetic surgical practices in rhinoplasty from the 1930s to the 1940s were recovered and briefly reviewed, and some of the most important clinical cases were presented. Other important events related to rhinoplasty, such as the establishment of the first national society of rhinoplasty in Chengdu, China in 2011 and the successful performance of the first national congress on rhinoplasty in Shanghai, China in 2012, were included.</p></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"4 4","pages":"Pages 149-153"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096691122000437/pdfft?md5=2c477a87cf1ce7a3249cb15f367c8058&pid=1-s2.0-S2096691122000437-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48093659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Corrigendum to: Efficacy and safety of sclerosants in the treatment of venous malformations: A network meta-analysis of randomized controlled trials 纠正:硬化剂治疗静脉畸形的有效性和安全性:随机对照试验的网络荟萃分析
Pub Date : 2022-12-01 DOI: 10.1016/j.cjprs.2022.11.002
Wei Lu , Zhenyu Yang , Zuoliang Qi , Xiaonan Yang
{"title":"Corrigendum to: Efficacy and safety of sclerosants in the treatment of venous malformations: A network meta-analysis of randomized controlled trials","authors":"Wei Lu ,&nbsp;Zhenyu Yang ,&nbsp;Zuoliang Qi ,&nbsp;Xiaonan Yang","doi":"10.1016/j.cjprs.2022.11.002","DOIUrl":"10.1016/j.cjprs.2022.11.002","url":null,"abstract":"","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"4 4","pages":"Page 208"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096691122000784/pdfft?md5=c84c79e3bb533fa2893e43682e256a5c&pid=1-s2.0-S2096691122000784-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49031659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral health-related quality of life between Chinese and American orthodontic patients: A two-center cross-sectional study 中美正畸患者口腔健康生活质量的双中心横断面研究
Pub Date : 2022-12-01 DOI: 10.1016/j.cjprs.2022.11.001
Youbai Chen , Tianqi Li , Yujian Xu , Jiahua Xing , Weiqian Jiang , Xiangye Yin , Haizhong Zhang , Meredith August , Katherine P. Klein , Tong Zhang

Background

Although oral health-related quality of life (OHRQoL) in orthodontic patients has been assessed in the past, to date, no study has compared the OHRQoL between two nations. We aimed to compare the OHRQoL between Chinese and American orthodontic patients.

Methods

We conducted a two-center questionnaire-based cross-sectional study among patients who underwent orthodontic treatments at the Chinese PLA General Hospital (PLAGH) in Beijing, China and Massachusetts General Hospital (MGH) in Boston, Massachusetts, United States. Candidate variables included the participating center, patients’' age, sex, Angle’s classification of malocclusion, evaluation stage, and appliances used. The primary outcome was patients’ OHRQoL assessed with the Oral Health Impact Profile-14 (OHIP-14). Descriptive statistics, stratification, and univariate and multivariate analyses were performed.

Results

The average age was lower for PLAGH patients than for MGH patients (21.1 ​± ​7.9 vs. 33.1 ​± ​14.6 years, P<0.001). The most common type of malocclusion was Angle’s Class III malocclusion at PLAGH (39%) and Class I malocclusion at MGH (59.5%). Clear aligners were used in 34.1% and 2.7% of the patients at MGH and PLAGH, respectively. OHIP-14 scores were lower for PLAGH patients than for MGH patients (18.4 ​± ​4.7 vs. 22.3 ​± ​7.4, P<0.001), particularly in functional limitation, psychological discomfort/disability, and handicap. Univariate regression analysis demonstrated that participating center, age, Class I malocclusion, and the use of clear aligners were significantly associated with overall OHIP-14 scores. Multivariate regression analysis demonstrated that patients at PLAGH were associated with lower OHIP-14 scores (coefficient: −3; 95% CI: −5, −1.3; P=0.001), and age was positively associated with OHIP-14 scores (coefficient: 0.1; 95% CI: 0.004, 0.13; P=0.038).

Conclusion

Chinese orthodontic patients had lower OHIP-14 scores, indicating a higher OHRQoL than American patients. In addition to the younger age, this difference may be attributed to the different ethical, cultural, educational, and socioeconomic background of Chinese and American orthodontic patients.

虽然过去已经对正畸患者的口腔健康相关生活质量(OHRQoL)进行了评估,但迄今为止,还没有研究对两个国家的OHRQoL进行比较。我们的目的是比较中国和美国正畸患者的OHRQoL。方法采用双中心问卷横断面研究,对在中国北京中国人民解放军总医院(PLAGH)和美国马萨诸塞州波士顿马萨诸塞州总医院(MGH)接受正畸治疗的患者进行调查。候选变量包括参与中心、患者年龄、性别、Angle错颌分类、评估阶段和使用矫治器。主要终点是用口腔健康影响量表-14 (OHIP-14)评估患者的OHRQoL。进行描述性统计、分层、单因素和多因素分析。结果PLAGH患者的平均年龄低于MGH患者(21.1±7.9岁∶33.1±14.6岁,P<0.001)。最常见的错牙合类型是PLAGH的Angle III类错牙合(39%)和MGH的I类错牙合(59.5%)。MGH和PLAGH分别有34.1%和2.7%的患者使用了透明矫正器。PLAGH患者的OHIP-14评分低于MGH患者(18.4±4.7比22.3±7.4,P<0.001),特别是在功能限制、心理不适/残疾和残疾方面。单因素回归分析显示,参与中心、年龄、I类错颌和使用矫正器与OHIP-14总分显著相关。多因素回归分析表明,PLAGH患者与较低的OHIP-14评分相关(系数:−3;95% ci:−5,−1.3;P=0.001),年龄与OHIP-14评分呈正相关(系数:0.1;95% ci: 0.004, 0.13;P = 0.038)。结论中国正畸患者OHIP-14评分低于美国患者,OHRQoL高于美国患者。除了年龄更小外,这种差异可能归因于中美正畸患者不同的伦理、文化、教育和社会经济背景。
{"title":"Oral health-related quality of life between Chinese and American orthodontic patients: A two-center cross-sectional study","authors":"Youbai Chen ,&nbsp;Tianqi Li ,&nbsp;Yujian Xu ,&nbsp;Jiahua Xing ,&nbsp;Weiqian Jiang ,&nbsp;Xiangye Yin ,&nbsp;Haizhong Zhang ,&nbsp;Meredith August ,&nbsp;Katherine P. Klein ,&nbsp;Tong Zhang","doi":"10.1016/j.cjprs.2022.11.001","DOIUrl":"10.1016/j.cjprs.2022.11.001","url":null,"abstract":"<div><h3>Background</h3><p>Although oral health-related quality of life (OHRQoL) in orthodontic patients has been assessed in the past, to date, no study has compared the OHRQoL between two nations. We aimed to compare the OHRQoL between Chinese and American orthodontic patients.</p></div><div><h3>Methods</h3><p>We conducted a two-center questionnaire-based cross-sectional study among patients who underwent orthodontic treatments at the Chinese PLA General Hospital (PLAGH) in Beijing, China and Massachusetts General Hospital (MGH) in Boston, Massachusetts, United States. Candidate variables included the participating center, patients’' age, sex, Angle’s classification of malocclusion, evaluation stage, and appliances used. The primary outcome was patients’ OHRQoL assessed with the Oral Health Impact Profile-14 (OHIP-14). Descriptive statistics, stratification, and univariate and multivariate analyses were performed.</p></div><div><h3>Results</h3><p>The average age was lower for PLAGH patients than for MGH patients (21.1 ​± ​7.9 vs. 33.1 ​± ​14.6 years, <em>P</em>&lt;0.001). The most common type of malocclusion was Angle’s Class III malocclusion at PLAGH (39%) and Class I malocclusion at MGH (59.5%). Clear aligners were used in 34.1% and 2.7% of the patients at MGH and PLAGH, respectively. OHIP-14 scores were lower for PLAGH patients than for MGH patients (18.4 ​± ​4.7 vs. 22.3 ​± ​7.4, <em>P</em>&lt;0.001), particularly in functional limitation, psychological discomfort/disability, and handicap. Univariate regression analysis demonstrated that participating center, age, Class I malocclusion, and the use of clear aligners were significantly associated with overall OHIP-14 scores. Multivariate regression analysis demonstrated that patients at PLAGH were associated with lower OHIP-14 scores (coefficient: −3; 95% CI: −5, −1.3; <em>P</em>=0.001), and age was positively associated with OHIP-14 scores (coefficient: 0.1; 95% CI: 0.004, 0.13; <em>P</em>=0.038).</p></div><div><h3>Conclusion</h3><p>Chinese orthodontic patients had lower OHIP-14 scores, indicating a higher OHRQoL than American patients. In addition to the younger age, this difference may be attributed to the different ethical, cultural, educational, and socioeconomic background of Chinese and American orthodontic patients.</p></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"4 4","pages":"Pages 171-177"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096691122000772/pdfft?md5=acc22cf6ec6219b9cd63e6888f2006bd&pid=1-s2.0-S2096691122000772-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43966229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A combined therapy for the repair of alar defects that consists of a modified spiral flap and postoperative nasal stent 改良螺旋瓣加鼻内支架联合治疗鼻翼缺损
Pub Date : 2022-12-01 DOI: 10.1016/j.cjprs.2022.10.003
Yinmin Wang , Cheng Huang , Youcong Ning , Rui Jin , Jun Yang , Lin Lu , Xusong Luo

Background

The repair of alar defects is challenging in clinics. Although skin grafts and nasolabial flaps are reliable, they can cause secondary post-surgical deformities.

Methods

In this report, we describe an alar spiral advancement flap with a subcutaneous pedicle combined with postoperative nasal stent therapy for the repair of alar defects.

Results

All cases showed slight asymmetry immediately after surgery, but at a median follow-up of 24 months, no cases of dissatisfaction with the nose shape or abnormal respiratory function were found. Almost all incision scars subsided within 12 months. In addition, all flaps that were dissected and rotated during the surgeries healed, and no signs of necrosis or development of vascular compromise were observed.

Conclusion

Our preliminary experience suggests that the alar spiral flap followed by nasal stent therapy provides stable recovery of appearance and function for alar defects during follow-ups and shows promise for future therapies.

背景鼻翼缺损的修复在临床上具有挑战性。虽然皮肤移植和鼻唇瓣是可靠的,但它们可能导致继发性术后畸形。方法采用带皮下蒂的鼻翼螺旋推进瓣联合鼻支架治疗鼻翼缺损。结果所有病例术后均有轻微不对称,中位随访24个月,未发现对鼻型不满意或呼吸功能异常的病例。几乎所有切口疤痕在12个月内消退。此外,所有在手术中剥离和旋转的皮瓣均愈合,未观察到坏死或血管受损的迹象。结论鼻翼螺旋瓣鼻支架治疗后鼻翼缺损的外观和功能恢复稳定,具有良好的临床应用前景。
{"title":"A combined therapy for the repair of alar defects that consists of a modified spiral flap and postoperative nasal stent","authors":"Yinmin Wang ,&nbsp;Cheng Huang ,&nbsp;Youcong Ning ,&nbsp;Rui Jin ,&nbsp;Jun Yang ,&nbsp;Lin Lu ,&nbsp;Xusong Luo","doi":"10.1016/j.cjprs.2022.10.003","DOIUrl":"10.1016/j.cjprs.2022.10.003","url":null,"abstract":"<div><h3>Background</h3><p>The repair of alar defects is challenging in clinics. Although skin grafts and nasolabial flaps are reliable, they can cause secondary post-surgical deformities.</p></div><div><h3>Methods</h3><p>In this report, we describe an alar spiral advancement flap with a subcutaneous pedicle combined with postoperative nasal stent therapy for the repair of alar defects.</p></div><div><h3>Results</h3><p>All cases showed slight asymmetry immediately after surgery, but at a median follow-up of 24 months, no cases of dissatisfaction with the nose shape or abnormal respiratory function were found. Almost all incision scars subsided within 12 months. In addition, all flaps that were dissected and rotated during the surgeries healed, and no signs of necrosis or development of vascular compromise were observed.</p></div><div><h3>Conclusion</h3><p>Our preliminary experience suggests that the alar spiral flap followed by nasal stent therapy provides stable recovery of appearance and function for alar defects during follow-ups and shows promise for future therapies.</p></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"4 4","pages":"Pages 154-157"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096691122000759/pdfft?md5=fcf41e6c06214cb08f24d61889a9a792&pid=1-s2.0-S2096691122000759-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45939732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Micropunch grafting for healing of refractory chronic venous leg ulcers 微穿孔移植术治疗难治性下肢慢性静脉性溃疡
Pub Date : 2022-12-01 DOI: 10.1016/j.cjprs.2022.10.001
Aya Mohamed Samy , Mostafa Abd El-Halim , Ahmed Hassan El-Sabbagh

Background

Chronic venous ulcers are a serious problem for both patients and physicians. The CEAP classification (clinical manifestations (C), etiologic factors (E), anatomic distribution of disease (A), and underlying pathophysiologic findings (P)) for chronic venous disorders (CVD) was developed in 1994. Published papers on CVD use all or part of the CEAP. Micropunch grafts, which are a variation of skin grafts, have been used with great success in plastic surgery for both esthetic and reconstructive purposes. This study aimed to assess the outcomes of micropunch grafting in the treatment of chronic refractory venous ulcers.

Methods

Patients with chronic venous ulcers who did not respond to conservative treatment for more than 6 months were included in the study. All patients underwent ulcer coverage by micropunch skin grafts using a micrometer. The patients were discharged on the same day as the surgery. Micropunch skin grafts were manually counted per square centimeter intraoperatively and during follow-up using Dermlite Dermatoschope™ II Pro HR. Patient satisfaction was assessed by using a questionnaire.

Results

Twenty patients underwent the surgery. Most of the patients were middle-aged males. The ulcers were predominantly small- and medium-sized. The mean operation time was 167.00 ​± ​86.01 ​min. After 6 months, the survival rate of the planted micrografts was 84%. Three ulcers had graft loss and two patients had an infection at the ulcer site, which was managed conservatively. The patients were followed-up for 14 months.

Conclusion

Micropunch grafting is a useful and convenient method for the treatment of difficult venous ulcers and can be performed on an outpatient basis.

背景:慢性静脉溃疡对患者和医生来说都是一个严重的问题。慢性静脉疾病(CVD)的CEAP分类(临床表现(C)、病因(E)、疾病解剖分布(A)和潜在病理生理表现(P))于1994年提出。已发表的CVD论文全部或部分使用CEAP。微穿孔移植物是皮肤移植物的一种变体,在整形外科中用于美容和重建目的取得了巨大的成功。本研究旨在评估微穿孔移植治疗慢性难治性静脉溃疡的效果。方法将保守治疗6个月以上无效的慢性静脉溃疡患者纳入研究。所有的病人都接受了用千分尺进行皮肤移植覆盖溃疡。患者于手术当日出院。在术中和随访期间,使用Dermlite Dermatoschope™II Pro HR对每平方厘米的微穿孔皮肤移植物进行人工计数。通过问卷调查评估患者满意度。结果20例患者行手术治疗。患者以中年男性居多。溃疡以中小型溃疡为主。平均手术时间为167.00±86.01 min。6个月后,移植的微移植物成活率为84%。3例溃疡有移植物丢失,2例溃疡处有感染,采用保守治疗。随访14个月。结论微穿孔移植术是治疗难治性静脉溃疡的一种简便易行的方法,可在门诊进行。
{"title":"Micropunch grafting for healing of refractory chronic venous leg ulcers","authors":"Aya Mohamed Samy ,&nbsp;Mostafa Abd El-Halim ,&nbsp;Ahmed Hassan El-Sabbagh","doi":"10.1016/j.cjprs.2022.10.001","DOIUrl":"10.1016/j.cjprs.2022.10.001","url":null,"abstract":"<div><h3>Background</h3><p>Chronic venous ulcers are a serious problem for both patients and physicians. The CEAP classification (clinical manifestations (C), etiologic factors (E), anatomic distribution of disease (A), and underlying pathophysiologic findings (P)) for chronic venous disorders (CVD) was developed in 1994. Published papers on CVD use all or part of the CEAP. Micropunch grafts, which are a variation of skin grafts, have been used with great success in plastic surgery for both esthetic and reconstructive purposes. This study aimed to assess the outcomes of micropunch grafting in the treatment of chronic refractory venous ulcers.</p></div><div><h3>Methods</h3><p>Patients with chronic venous ulcers who did not respond to conservative treatment for more than 6 months were included in the study. All patients underwent ulcer coverage by micropunch skin grafts using a micrometer. The patients were discharged on the same day as the surgery. Micropunch skin grafts were manually counted per square centimeter intraoperatively and during follow-up using Dermlite Dermatoschope™ II Pro HR. Patient satisfaction was assessed by using a questionnaire.</p></div><div><h3>Results</h3><p>Twenty patients underwent the surgery. Most of the patients were middle-aged males. The ulcers were predominantly small- and medium-sized. The mean operation time was 167.00 ​± ​86.01 ​min. After 6 months, the survival rate of the planted micrografts was 84%. Three ulcers had graft loss and two patients had an infection at the ulcer site, which was managed conservatively. The patients were followed-up for 14 months.</p></div><div><h3>Conclusion</h3><p>Micropunch grafting is a useful and convenient method for the treatment of difficult venous ulcers and can be performed on an outpatient basis.</p></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"4 4","pages":"Pages 166-170"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096691122000735/pdfft?md5=14befb65d6d2779aa8fcbe0e26b53418&pid=1-s2.0-S2096691122000735-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46467897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive pathogenesis and clinical therapy in striae distensae: An overview and current perspective 扩张纹的综合发病机制与临床治疗:综述与研究进展
Pub Date : 2022-12-01 DOI: 10.1016/j.cjprs.2022.10.002
Yichen Shen , Qianqian Pang , Jinghong Xu

The pathogenesis of striae distensae (SD) is complicated and has not yet been fully elucidated. Hormonal changes, overstretched skin, and structural and functional changes in the skin may be crucial factors in the development of SD. Therapy aims to stimulate dermal collagen synthesis and improve skin texture. Mainstream treatments include topical medications, chemical peeling, laser and radiofrequency therapy, microdermabrasion, microneedle therapy, and filler injection therapy. In the present review, we summarize current perspectives on the pathogenesis and clinical therapy of SD.

腹胀纹的发病机制复杂,尚未完全阐明。激素变化、皮肤过度拉伸、皮肤结构和功能改变可能是SD发生的关键因素。治疗旨在刺激真皮胶原蛋白合成,改善皮肤质地。主流治疗方法包括局部药物治疗、化学脱皮、激光和射频治疗、微磨皮、微针治疗和填充物注射治疗。本文就SD的发病机制和临床治疗进行综述。
{"title":"Comprehensive pathogenesis and clinical therapy in striae distensae: An overview and current perspective","authors":"Yichen Shen ,&nbsp;Qianqian Pang ,&nbsp;Jinghong Xu","doi":"10.1016/j.cjprs.2022.10.002","DOIUrl":"10.1016/j.cjprs.2022.10.002","url":null,"abstract":"<div><p>The pathogenesis of striae distensae (SD) is complicated and has not yet been fully elucidated. Hormonal changes, overstretched skin, and structural and functional changes in the skin may be crucial factors in the development of SD. Therapy aims to stimulate dermal collagen synthesis and improve skin texture. Mainstream treatments include topical medications, chemical peeling, laser and radiofrequency therapy, microdermabrasion, microneedle therapy, and filler injection therapy. In the present review, we summarize current perspectives on the pathogenesis and clinical therapy of SD.</p></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"4 4","pages":"Pages 203-207"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096691122000747/pdfft?md5=11fe1f7e70e39c30ec32896c3949f2e9&pid=1-s2.0-S2096691122000747-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43528520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polydeoxyribonucleotide: A promising skin anti-aging agent 聚脱氧核糖核苷酸:一种很有前途的皮肤抗衰老剂
Pub Date : 2022-12-01 DOI: 10.1016/j.cjprs.2022.09.015
Aawrish Khan, Guobao Wang, Feng Zhou, Lunli Gong, Jun Zhang, Lili Qi, Haiyan Cui

Polydeoxyribonucleotide (PDRN) consists of DNA fragments with molecular weights ranging from 50 to 1 500 ​kDa, which are mainly extracted from the sperm cells of salmon trout or chum salmon. Many preclinical and clinical studies have demonstrated the properties of PDRN. These include anti-inflammatory, anti-apoptotic, anti-osteoporotic, anti-melanogenetic, anti-allodynic, anti-osteonecrotic, bone regenerative, tissue damage preventive, anti-ulcerative, and wound healing properties, which are mediated by the activation of the adenosine A2A receptor and salvage pathways. Moreover, PDRN promotes angiogenesis, cellular activity, collagen synthesis, soft tissue regeneration, and skin priming and revitalization and can be used to treat hyperpigmentation. Therefore, this review assessed the potential use of PDRN as an anti-aging agent for the skin.

多脱氧核糖核苷酸(PDRN)由分子量在50 ~ 1 500 kDa之间的DNA片段组成,主要从鲑鱼、鳟鱼和鲑鱼的精子细胞中提取。许多临床前和临床研究已经证明了PDRN的特性。这些包括抗炎、抗凋亡、抗骨质疏松、抗黑素生成、抗异变、抗骨坏死、骨再生、组织损伤预防、抗溃疡和伤口愈合特性,这些特性是由腺苷A2A受体的激活和修复途径介导的。此外,PDRN促进血管生成,细胞活性,胶原合成,软组织再生,皮肤启动和振兴,可用于治疗色素沉着。因此,本综述评估了PDRN作为皮肤抗衰老剂的潜在用途。
{"title":"Polydeoxyribonucleotide: A promising skin anti-aging agent","authors":"Aawrish Khan,&nbsp;Guobao Wang,&nbsp;Feng Zhou,&nbsp;Lunli Gong,&nbsp;Jun Zhang,&nbsp;Lili Qi,&nbsp;Haiyan Cui","doi":"10.1016/j.cjprs.2022.09.015","DOIUrl":"10.1016/j.cjprs.2022.09.015","url":null,"abstract":"<div><p>Polydeoxyribonucleotide (PDRN) consists of DNA fragments with molecular weights ranging from 50 to 1 500 ​kDa, which are mainly extracted from the sperm cells of salmon trout or chum salmon. Many preclinical and clinical studies have demonstrated the properties of PDRN. These include anti-inflammatory, anti-apoptotic, anti-osteoporotic, anti-melanogenetic, anti-allodynic, anti-osteonecrotic, bone regenerative, tissue damage preventive, anti-ulcerative, and wound healing properties, which are mediated by the activation of the adenosine A<sub>2A</sub> receptor and salvage pathways. Moreover, PDRN promotes angiogenesis, cellular activity, collagen synthesis, soft tissue regeneration, and skin priming and revitalization and can be used to treat hyperpigmentation. Therefore, this review assessed the potential use of PDRN as an anti-aging agent for the skin.</p></div>","PeriodicalId":65600,"journal":{"name":"Chinese Journal of Plastic and Reconstructive Surgery","volume":"4 4","pages":"Pages 187-193"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2096691122000723/pdfft?md5=186b600ebde4bbd7ab89c826778007b6&pid=1-s2.0-S2096691122000723-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45586430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Chinese Journal of Plastic and Reconstructive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1